Elevance Health, Inc. (ELV)

Basic

  • Market Cap

    $113.51B

  • EV

    $128.42B

  • Shares Out

    234.96M

  • Revenue

    $168.63B

  • Employees

    102,300

Margins

  • Gross

    27.04%

  • EBITDA

    6.03%

  • Operating

    5.32%

  • Pre-Tax

    4.7%

  • Net

    3.63%

  • FCF

    4.89%

Returns (5Yr Avg)

  • ROA

    5.71%

  • ROE

    15.58%

  • ROCE

    13.73%

  • ROIC

    11.86%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $565.26

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $711.73

  • Earnings (Dil)

    $25.65

  • FCF

    $34.53

  • Book Value

    $163.57

Growth (CAGR)

  • Rev 3Yr

    12.81%

  • Rev 5Yr

    13.03%

  • Rev 10Yr

    9.44%

  • Dil EPS 3Yr

    9.82%

  • Dil EPS 5Yr

    8.25%

  • Dil EPS 10Yr

    10.88%

  • Rev Fwd 2Yr

    5.99%

  • EBITDA Fwd 2Yr

    10.38%

  • EPS Fwd 2Yr

    12.92%

  • EPS LT Growth Est

    11.9%

Dividends

  • Yield

    —

  • Payout

    22.12%

  • DPS

    $5.72

  • DPS Growth 3Yr

    16.15%

  • DPS Growth 5Yr

    14.16%

  • DPS Growth 10Yr

    15.01%

  • DPS Growth Fwd 2Yr

    9.35%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Premiums and Annuity Revenues

85,421.0

94,173.0

104,109.0

117,373.0

133,229.0

141,362.0

Total Interest And Dividend Income

970.0

1,005.0

877.0

1,378.0

1,485.0

1,669.0

Gain (Loss) on Sale of Investments, Total

—

—

—

—

—

—

Other Revenues, Total

5,700.0

9,034.0

16,882.0

19,892.0

21,885.0

25,595.0

Total Revenues

92,091.0

104,212.0

121,868.0

138,643.0

156,599.0

168,626.0

Total Revenues % Chg.

2.3%

13.2%

16.9%

13.8%

13.0%

10.0%

Policy Benefits

71,895.0

81,786.0

88,045.0

102,645.0

116,487.0

123,036.0

Amortization of Goodwill and Intangible Assets

358.0

338.0

361.0

441.0

767.0

915.0

Selling General & Admin Expenses, Total

14,020.0

15,356.0

25,202.0

26,600.0

30,682.0

35,704.0

Total Operating Expenses

86,273.0

97,480.0

113,608.0

129,686.0

147,936.0

159,655.0

Operating Income

5,818.0

6,732.0

8,260.0

8,957.0

8,663.0

8,971.0

Interest Expense, Total

-739.0

-745.0

-785.0

-802.0

-855.0

-1,004.0

EBT, Excl. Unusual Items

5,079.0

5,987.0

7,475.0

8,155.0

7,808.0

7,967.0

Restructuring Charges

—

—

-653.0

-202.0

-39.0

-39.0

Asset Writedown

—

—

—

-7.0

—

—

Legal Settlements

—

—

-548.0

—

—

—

Other Unusual Items

-11.0

-2.0

-36.0

-21.0

—

—

EBT, Incl. Unusual Items

5,068.0

5,985.0

6,238.0

7,925.0

7,769.0

7,928.0

Income Tax Expense

1,318.0

1,178.0

1,666.0

1,830.0

1,750.0

1,760.0

Earnings From Continuing Operations

3,750.0

4,807.0

4,572.0

6,095.0

6,019.0

6,168.0

Earnings Of Discontinued Operations

—

—

—

—

—

—

Minority Interest

—

—

—

9.0

6.0

-41.0

Net Income

3,750.0

4,807.0

4,572.0

6,104.0

6,025.0

6,127.0

Net Income to Common Incl Extra Items

3,750.0

4,807.0

4,572.0

6,104.0

6,025.0

6,127.0

Net Income to Common Excl. Extra Items

3,750.0

4,807.0

4,572.0

6,104.0

6,025.0

6,127.0

Total Shares Outstanding

257.4

252.9

245.4

241.8

238.0

234.9

Weighted Avg. Shares Outstanding

258.1

255.5

250.8

243.8

240.0

236.9

Weighted Avg. Shares Outstanding Dil

264.2

260.3

254.3

246.8

242.8

238.8

EPS

14.5

18.8

18.2

25.0

25.1

25.9

EPS Diluted

14.2

18.5

18.0

24.7

24.8

25.7

EBITDA

6,485.0

7,415.0

9,002.0

9,774.0

9,739.0

10,166.0